NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID
Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first phase 3, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID (LC), also known as long-haul…
